The T cell product interleukin 5 (IL 5) has been shown to be a key factor in the development and the maturation of the eosinophilic cell lineage . We report here on the detection of human IL5 receptors on eosinophilic sublines of the promyelocytic leukemia HL-60. Sodium butyrate, which initiates differentiation to mature eosinophils, also induces the appearance of high affinity (Kd 1-5 x 10 -11 M) IL5 binding sites on these cells. The receptors are specific for 11,5, since binding of radiolabeled ligand can only be inhibited with homologous or murine IL-5 and not by other cytokines. We further show that the receptors are functional, since 116 can stimulate the proliferation of these cells. Affinity crosslinking of surface-bound 1251 human IL-5 or 35S mouse IL5 identified two membrane polypeptides of -60 and -130 kD to which 1175 is closely associated. The presence of granuloryte/macrophage-colony-stimulating factor or tumor necrosis factor during butyrate induction decreased the expression of 11,5 binding sites compared with control cultures. The identification and characterization of human 1175 receptors on HL60 sublines should provide new insight into the role of this cytokine in eosinophil differentiation .
Summary
The T cell product interleukin 5 (IL 5) has been shown to be a key factor in the development and the maturation of the eosinophilic cell lineage . We report here on the detection of human IL5 receptors on eosinophilic sublines of the promyelocytic leukemia HL-60. Sodium butyrate, which initiates differentiation to mature eosinophils, also induces the appearance of high affinity (Kd 1-5 x 10 -11 M) IL5 binding sites on these cells. The receptors are specific for 11,5, since binding of radiolabeled ligand can only be inhibited with homologous or murine IL-5 and not by other cytokines. We further show that the receptors are functional, since 116 can stimulate the proliferation of these cells. Affinity crosslinking of surface-bound 1251 human IL-5 or 35S mouse IL5 identified two membrane polypeptides of -60 and -130 kD to which 1175 is closely associated. The presence of granuloryte/macrophage-colony-stimulating factor or tumor necrosis factor during butyrate induction decreased the expression of 11,5 binding sites compared with control cultures. The identification and characterization of human 1175 receptors on HL60 sublines should provide new insight into the role of this cytokine in eosinophil differentiation . E osinophils are specialized granulocytes found in blood and peripheral tissues . They are present in relatively low numbers in the circulation of healthy individuals, but their number increases dramatically in certain pathological situations, such as parasitic infections and allergic diseases (reviewed in reference 1). This selective eosinophilia suggests the existence ofa specific mechanism controlling eosinophilic growth and/or differentiation. Although IL3, granuloryte/macrophage CSF (GM-CSF),' and IL5 all induce eosinophil differentiation, only IL5 appears to be specific for the eosinophil lineage. Both mouse (m) and human (h) 11,5 are potent and specific stimuli for eosinophil colony formation in semisolid cultures (2, 3), and for eosinophil growth and differentiation in liquid cultures (4-6). Furthermore, IL-5 stimulates mouse and human eosinophil function (7, 8) . Also, there is evidence pointing to the importance of IL5 as a mediator ofeosinophilia in vivo. For example, antibodies against IL5 inhibit helminthinduced eosinophilia in mice (9), and neutralize the activity that converts normodense eosinophils to a functionally activated hypodense phenotype in serum of patients with idiopathic hypereosinophilic syndrome (10).
'Abbreviations used in this paper: Con A-sup, Con A supernatant ; GM-CSF, granuloryte/macrophage CSF; h, human ; m, mouse ; RT, room temperature. Murine IL5 was originally described as a T cell-replacing factor (TRF) and as a B cell growth factor (BCGF II), based on its capacity to induce proliferation and Ig secretion by activated murine B cells (reviewed in reference 11) . It has been impossible to demonstrate similar activities of IL-5 on human B cells in a wide range ofassay systems (12), apart from some early conflicting reports (3, 13) . Nevertheless, hIL5 is active on mouse B cells, but with very low specific activity. The availability of IL5-responsive B cell leukemic cells and 11,5-dependent early B cell lines facilitated the characterization of IL5-Rs on murine B cells . 1175 binding sites displaying both high (Kd 10-11 M) and low (10 -9 M) affinity have been found on a number of such cell lines (14, 15) . Crosslinking ofbound radiolabeled IL-5 gave evidence for two specifically crosslinked polypeptides, suggesting that the IM associates to more than one polypeptide chain at the cell membrane . The complexity of the IL5R was further illustrated with the isolation of several mAbs directed against epitopes on the IL 5R (16, 17) . Although all these antibodies inhibit IL5 biological activity and binding of IL-5 to mouse B cells, they do not seem to recognize the same molecules . Some antibodies immunoprecipitate predominantly polypeptides with a molecular weight similar to that of the larger crosslinked chain (16) , while others recognize molecules that may correspond to the smaller crosslinked polypeptide (17) . Also, the cell populations that are surface stained with these different antibodies do not overlap completely.
Much less is known about IIr5Rs on mouse or human eosinophils . One explanation for this is the lack of established IL5-responsive eosinophilic cell lines. To our knowledge, no such cell lines have been described so far. The human promyelocytic leukemia cell line HL60 has been an important model of myelocytic cellular differentiation (18) . By the addition of specific chemical agents to the culture medium, HIr60 can be induced to mature to cells with many of the functional, morphological, and biochemical features of macrophages, neutrophils, or eosinophils (19, 20) . Under normal culture conditions, few HL60 cells differentiate to eosinophils (21, 22) . However, after passage in alkaline medium, HIr60 becomes committed to differentiate primarily along the eosinophilic lineage, when they are subsequently cultured in presence of butyric acid (23) . We hypothesized that such cells, by analogy with normal eosinophils, were capable of expressing I1r5Rs. Here, we describe that HIr60, committed to eosinophil differentiation, start to express specific high affinity binding sites for 116 upon maturation induced by butyrate . We further demonstrate that these receptors are functional and that cell-bound 11,5 is associated with two membrane proteins with molecular weights of "130,000 and "60,000.
Materials and Methods
Ce11 Lines. HIr60 cells were obtained from the American Type Culture Collection (Rockville, MD) and were maintained in RPMI 1640 medium (Gibco Laboratories, Grand Island, NY) supplemented with 10% FCS (Gibco Laboratories) and gentamycin (25 Fog/ml). Clone 18.16 is a subdone of HL-60 that was selected for IL5 binding. Briefly, cells were cloned at 100-300 cells/ml in RPMI 1640, 10% FCS, 20 ng/ml human GM-CSF, and 0.92 methyl cellulose (24) . After 2 wk, colonies were randomly picked and expanded. Different clones were then passaged in alkaline medium (pH 7 .6, 25 mM Tricine) and induced to differentiate with butyrate as described (20) . One of the clones that showed specific binding of 11,5 (clone 18) was subjected to a second round of subdoning. Clone 18 .16 was selected on the basis of highest 116 binding. Clone 15 and clone 2 cells are sublines of H1r60 with a tendency toward eosinophilic differentiation. Their isolation and characterization have been described elsewhere (25) . Aliquots of fresh cells were thawed every month. To induce ILSRs, the cells were incubated at 2 x 105 cells/ml with 0.4 mM sodium butyrate for 7 d. B13 is an IL3-or IL5-dependent Ly-1 * murine Pro-B lymphocyte clone (26) , and was kindly given to us by R. Palacios (Basel Institute for Immunology, Basel, Switzerland) . These cells were cultured in DMEM supplemented with 5% FCS, 25 ug/ml gentamycin, 50 ;&M 2-ME, and 100 U/ml recombinant mIL5 .
Cytokines and mAbs. rhIL5 was obtained from transformed Saccharompces cetmisiae and recombinant baculovirus-infected Sf9 cells, as described elsewhere (27) . Baculovirus-derived 11,5 was purified from the supernatant of the cells to homogeneity using single-step immunoaffinity chromatography with an anti-hIL5 mAb 5A5 U.
Van der Heyden, unpublished results, and see below). rmIIr5 was also produced in the baculovirus system (27) and purified to homogeneity. Briefly, the 50-80% (NH4)2SO4 precipitation fraction of the Sf9 culture medium was dialyzed against 20 mM Tris HCl, pH 7.0, and loaded on a Mono-Q column (Pharmacia Fine
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Human Interleukin 5 Receptors on Eosinophilic Cells Chemicals, Uppsala, Sweden). Under these conditions, mIL5 does not bind to the matrix, in contrast to the majority of proteins . The flow trough was brought to pH 9 .0 with ethanolamine and reloaded on Mono-Q. The mIL5 that was bound to the matrix this time was eluted at 65 mM NaCl using a linear gradient . Purity (>95%) was evaluated by SDS-PAGE according to Laemmli (28) . The biological activity of hIIr5 and mIL5 was 5 x 104 and 5 x 10' U/mg, respectively, as measured in the B13 proliferation assay (see below) . 1 U of IL5 is defined as the activity that causes 50% of the maximal incorporation. Recombinant human GM-CSF and G-CSF were generous gifts of Dr. J. DeLamarter, and hIL10 was obtained from Dr. A. Shaw (both from Glaxo IMB, Geneva, Switzerland) . rhI1r3 was kindly given by Dr. Y Furuichi (Nippon Roche Research Center, Kamakura, Japan) . Y Guisez (State University of Ghent) provided us with rhI1r6. Production and purification of rhTNF-a have been described elsewhere (29) . Supernatant of Con A-stimulated human PBL (Con A-sup) was prepared by standard procedures . 5A5 is a mouse mAb (IgG1 class) against hIIr5 that neutralizes biological activity, as measured in the B13 proliferation assay Q . Van der Heyden, unpublished results) . The rat antiIIx5R mAb R52.120 inhibits the biological activity of mIL5 and the binding to its receptor (16) , and was kindly given to us by Dr. A. Rolink (Basel Institute for Immunology). Human IgE was obtained from Allergene, Dublin, Ireland. Radiolabeling of IL5. I'll-labeled hIL5 and mIL5 were prepared from purified IL5 with the IODO-GEN (1,3,4,6-tetrachloro3a,6a-diphenylglycoluril) iodination reagent (Pierce Chemical Co ., Rockford, IL) according to the manufacturer's instruction. Briefly, 40 jug of hIIr5 or mIL5 was incubated with 1 mCi Na '25I (sp act, 2,000 Ci/mmol; Amersham International, Amersham, UK) in phosphate buffer, pH 7.6, for 10 min at 4°C in a glass tube that was previously coated with 2 Wg iodogen. Radiolabeled 11,5 was separated on a gel filtration column (PD-10; Pharmacia Fine Chemicals) in PBS containing 0.25% gelatin. The specific radioactivity of these preparations was routinely between 3 and 10 p. Ci/wg protein. After iodination, 10-50% of the IL5 remained biologically active, as determined in the B13 bio-assay (see below) . The purity of the labeled hIIr5 was checked by SDS-PAGE and autoradiography ( Fig. 1) . It consisted of a dimer with the expected molecular mass of 30 kD. Biosynthetically labeled I'S mIL5 was producedby injection in Xenopus kevis oocytes of SP6-RNA polymerase transcripts made using a pSP64TmIL5 plasmid (27) . Batches of five oocytes were incubated for 3 d at 18°C in 50 pl oocyte medium with 5,u1 "S-methionine (>1,000 Ci/mmol; Amersham International). Supernatants were collected and passed over a Sephadex-G25 column to remove unincorporated "S-methionine. mIL5 was found to be the major labeled protein upon SDS-PAGE analysis (not shown) . The specific activity of the IIS-mIL5 was calculated to be between 100 and 300 uCi/,ug.
Binding Assay. Binding was performed according to the protocol described by Robb et al . (30) with a constant amount of 12'I-hIL5, or with serial dilutions of 1251-labeled human or mouse 11,5 . To measure nonspecific binding, a parallel series of tubes containing a 100-fold excess of cold IL5 was included . To assess equilibrium binding of 11,5 to HL60 cells, the samples were incubated for 2 h at 4°C. During incubation, the tubes were placed on a rotation wheel to avoid aggregation of the cells. Subsequently, the suspension was layered onto a 0.5-ml phthalate oil (di-n-butylphthalate/dinonylphthalate, 2:1 [vol/vol], density, 1.02 g/ml) mixture (31) in a 1.5-ml Eppendorf tube and centrifuged at 12,000 rpm for 5 min. The tips of the tubes were cut off with a glowing razor blade, placed in vials, and counted in a gamma counter (minigamma LKB ; LKB Instruments Inc ., Turku, Finland). Specific binding was determined as the difference between total binding and nonspecific binding in the presence of 100-fold molar excess of cold ligand . The dissociation constant (Kd) and number of binding sites per cell were calculated by Scatchard analysis ofthe saturation binding data (32) with the computer program LIGAND (33) . The number of binding sites was calculated assuming that dimeric 11,5 bound to the receptor, since the biologically active form of IL5 is a dimer (27, 34) . IL5 Biological Assays. We measured the biological activity of both mIL5 and hIL5 preparates by testing their capacity to stimulate proliferation of HL60 clone 15 and B13 cells. Butyrate-induced HL60 done 15 cells grow independently of exogenous added growth factors, but proliferation can be increased twofold by addition of 11,5 or GM-CSF (see Results) . HL60 clone 15 cells were induced to differentiate with 0.4 mM sodium butyrate for 4 d before usage. Murine B13 cells are completely dependent on IL3 or IL5 for growth (26) . They were carefully washed and incubated in IL5-free medium for 2 h to remove remaining traces of IL5 . Cytokine samples were serially diluted in 96-well fiat-bottomed microtiter plates (Nunc, Roskilde, Denmark) in HL60 culture medium supplemented with 0 .4 mM sodium butyrate or in B13 culture medium. 141,60 or B13 cells were plated at a density of 5 x 10'/ml in 200 Al medium. Culture plates were incubated for 3 d at 37°C in a humidified atmosphere. Cell proliferation was determined by ['H]thymidine uptake (0.5 gCi/well, 5 mCi/mmol; Amersham International) during the last 6 h of the culture period. The data are expressed as the mean counts per minute of triplicate cultures.
Chemical Crosslinking of IL5 Binding Proteins on the HL60 Clone 15 Surface. 2 x 10' HL60 clone 15 cells were incubated for 2 h at 4°C in 0 .5 ml binding medium with 5 nM ' 251-hIL5 (10 ACi/Ag) or 1 nM 3 'S-mIL5, alone or in presence of 100-fold excess of unlabeled ligand . Subsequently, the cells were washed twice with ice-cold HBSS to remove unbound 11.6 . Crosslinking was carried out with the homobifunctional crosslinker BY (bis [sulfosuccinimidyl] suberate; purchased from Pierce Chemical Co.). The reaction was performed essentially as described by Mita et al. (14) . 107 cells were resuspended in 1 ml of HBSS, and crosslinker (20 Al at 50 mM in dimethyl sulfoxide) was added to a final concentration of 1 mM. As control, the other half of the cells was resuspended in HBSS with 20 Al dimethyl sulfoxide only. The samples were incubated for 30 min on ice, and the reaction was stopped by addition of 50 Al 1 M glycine during the last 5 min of the incubation . Thereafter, cells were centrifuged, washed once in 1 ml HBSS, and resuspended in 300 Al lysis buffer (PBS con- taining 2 mM EDTA, 2 mM EGTA, 2 mM PMSF, 10 AM pepstatin, 10 AM leupeptin, 2 mM o-phenantroline, 200 kallikrein inhibitor U/ml aprotinin, and 1% Triton X-100) . Nuclei and other cell debris were removed by centrifugation for 10 min at 4°C in a microcentrifuge . 150 Al of cell extract was analyzed on a 7.5% SDS gel . After electrophoresis, the gel was exposed to X-OMAT AR film (Kodak, Rochester, NY) . In case of crosslinking with 'sSmIL5, the gel was submerged in ENHANCE (New England Nuclear, Boston, MA) before autoradiography.
Results
Induction ofIL5 Binding Sites on Established Eosinophilic Sublines from HL60. HL60 promyelocytic leukemia cells can be induced to differentiate to neutrophils, macrophages, and eosinophils. To select for cells expressing IL5Rs, HIr60 cells were subcloned and cultured under conditions that allowed differentiation along the eosinophilic cell lineage (see Materials and Methods) . After differentiation, induced by butyrate, some clones showed significant binding of 125 I-hIL5 to their cell surface (data not shown) . One of these, clone 18 .16, displayed -500 IL5 binding sites after 8 d of butyrate treatment (Fig.  2) . Fischkoff isolated clones of HIr60, previously cultured for prolonged periods under alkaline conditions, that differentiated with a high rate to eosinophils, asjudged by morphological and cytochemical criteria (25) . The propensity of these cells to differentiate to eosinophils persists for months after they have been removed from the alkaline environment . Two of these cell lines, clone 2 and clone 15, were induced to differentiate with butyrate and were tested for IL-5 binding. As can be seen in Fig. 2, both Table 1 summarizes the results of such analysis. Binding of labeled human IL-5 can be successfully blocked with cold hIL5 and mIL5, and with anti-hIL5 mAb 5A5, which is also a potent inhibitor of hIL5 biological activity. hIL5 and mIL5 inhibit binding at similar concentrations . Other cytokines, such as IL3, GM-CSF, and IL6, fail to compete for 125 1-IL5 binding . mAb R52 .120, which recognizes an epitope of the mIL 5R and Table 1 . Competition for the Binding of '2s 1-labeled hIL-5 to HL60 Clone 15 (Induced with 0.4 mM Na-butyrate for 7 d) 2 .5 x 106 cells and 3 x 10 -1°M of 1251 IL-5 were incubated for 1 h at room temperature in 250 Al binding medium with indicated amounts of cytokines or antibodies . The fraction of label bound to the cells was determined as described in Materials and Methods .
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Human Interleukin 5 Receptors blocks binding of mIL5 on mouse B cells (16), does not interfere with IL5 binding on these human cells . To establish optimal parameters for hIL5 binding to HL60, cells were incubated at different temperatures for different times with radiolabeled hIL5. Measurement of the time course of 'zsl-IL5 binding to these cells at 37°C showed a rapid association of label . At 37°C and at room temperature (RT) (±21°C), maximum levels of specific binding (after subtraction of nonspecific background) were reached after -10-15 min . Even at 4°C there was no significant change anymore after 15 min. The total amount of cell-associated label at 37°C started to decline after 30 min (Fig. 3) . At RT and at 37°C, nonspecific binding kept increasing, while at 4°C, it remained constant after -1 h. We therefore used incubation at 4°C for further experiments. Equilibrium Binding of IL5 to HL60 Clone 15 Cells. Table 2 is a summary of several binding experiments performed with labeled hIL5 and/or mIL5 . From the competition experiment (Table 1) , we could expect that mIL5 would bind to HL60 with an affinity comparable with that of hIL5. Table 2 shows that this is indeed the case. In separate binding experiments, we measured a Kd value between 10 and 50 pM for both hIL5 and mIL5 . mIL5-dependent B cell lines display two classes (high and low affinity) of IL5Rs (14, 15 such as cell density or pH of the medium influence the efficiency of the induction . Biological Activity ofIL5 on HL60 Clone 15 Cells . We investigated if the IL5Rs that we could detect on these cells were functional, i.e., if they could transmit a biological signal . Clone 15 cells are not dependent on IL5 for proliferation . However, we found that IL5 increased their uptake of [ 3H]thymidine by a factor of two (Table 3 ) . hIL5 and mIIL5 were equally efficient in stimulating this response. The concentration of IL5 that, on average, induced 50% of maximal stimulation is in the range of 100 pg/ml or 3 x 10' 12 M, i.e., -1/10 of the Kd . GM-CSF also has a proliferative effect on these cells, which is consistent with published data (35) . While hIIL5 and mIL5 have comparable specific activities when tested on HL60, we found, in agreement with others (12, 36) , that the specific activity of hIL5 on murine B cells is >100-fold lower than that of mIIr5.
Affinity Crosslinking ofRadiolabeled IL5 to HL60 Cells. Normal H1r60 and clone 15 cells, cultured in presence or absence of butyrate, were incubated with 125 1_hIIr5 . Bound IL5 was crosslinked with BS3, as described in Materials and Methods, and the reaction products were analyzed by SDS-PAGE . The results are shown in Fig . 5 A . Two major IL5-crosslinked complexes were identified in clone 15 cell extracts. In lysates of cells induced to differentiate for 7 d with butyrate, the same bands could be observed but their intensity was markedly increased . The crosslinking products were specific for IL5 binding since excess of unlabeled IL5 or absence of crosslinking reagent abolished the presence of the bands on the gel . No bands could be detected in wild-type HIr60, suggesting that their expression is correlated with the selection for eosinophilic phenotype. The molecular mass of the ra- mIIL5 labeled to high specific activity in the oocyte system (Fig. 5 B) . Two complexes of -175 and -95 kD could be observed under nonreducing conditions from butyrate-induced clone 15 cells. Under reducing conditions, an upper band of 150 kD and two lower bands of 82 and 75 kD could be identified . The double band probably reflects heterogeneity of the biosynthetically 35S-labeled IL5 due to differential glycosylation (see uncrosslinked IM molecules) . The formation of these radiolabeled complexes could be competed with excess cold mIIr5 or hIIr5, indicating that both IL5 species bind to the same molecules .
Human Interleukin 5 Receptors on Eosinophilic Cells
Proliferation of butyrate-induced HL-60 clone 15 cells and of B13 cells was determined as described in Materials and Methods. The data represent mean cpm ± SD . Values that correspond roughly to 50% of maximal growth stimulation are underlined .
Effect of Various Cytokines on ILSR Expression . Butyrateinduced clone 15 cells expressed maatimally -2,000 ILSRs per cell . We tried to increase this number by growing the cells in the presence of different cytokines. Clone 15 cells were incubated for 3 d in butyrate. Subsequently, various agents were added during the last 4 d of the induction period . From the different cultures, the same number of cells were incubated with 125 1-11,5, and specifically bound IM was determined . As can be seen in Fig. 6 , none of the cytokines tested could further increase IIr5R expression . In contrast, some factors like TNF and GM-CSF, as well as supernatant from Con A-stimulated lymphocytes, decreased IM binding. None of the factors had a negative effect on the viability or the growth rate of these cells (not shown) . IgE can activate eosinophils, as monitored by the secretion of eosinophil peroxidase and Membrane-bound labeled 11r5 was crosslinked, as described in Materials and Methods, and the reaction products were analyzed by SDS-PAGE in presence of 2-ME. The autoradiography was developed after 4 wk of exposure. The uncrosslinked IL5 ran off the 7.5% gel. (B) Fluorograph of crosslinking of 35S-labeled mIIr5 bound to butyrate-induced clone 15 cells. The crosslinked products were analyzed under reducing and nonreducing conditions. The autoradiography was exposed for 4 d. Figure 6 . Effect of various reagents on IL5R expression . Clone 15 cells were cultured for 3 d in presence of butyrate. The suspension was distributed at 2 .5 x 105 cells/ml into separate culture bottles in medium with butyrate . Various agents were added at the following concentrations : hTNF-a, 10; U/ml; h11,10, 1 ng/ml ; h1Ir6, 6 ng/ml ; hIL3, 0.15 kg/ml; hGM-CSF, 10 ng/ml ; hG-CSF, 2 ng/ml ; h1gE, 1 ug/ml ; Con A-sup, 25% . The cells were further cultured for 4 d. platelet-activating factor, and low affinity receptors for IgE (Fc,R2, CD23) have been found on eosinophils (37, 38) . But, we found no effect of IgE on IL-5R expression of done 15 .
Discussion
So far, the only well-established biological role of IL5 in the human system is its activity as an eosinophil differentiation factor. Consequently, we searched for suitable eosinophilic cells to screen for hI1r5Rs. The promyelocytic leukemia cell line H1r60 is capable of being selectively induced to differentiate to eosinophils with butyric acid if they have previously been cultured under alkaline conditions (23) . Here, we describe the detection and characterization of IL5Rs on H1r60 sublines that were selected for their propensity towards eosinophil differentiation . To our knowledge, this is the first report on IL5R expression by human cells.
The production and function of eosinophils is controlled by at least three hemopoietic growth factors, namely IL3, GM-CSF, and IL5 . IL3 and GM-CSF bind to high affinity receptors on the surface of human eosinophils. The reciprocally inhibit each others binding, suggesting a common binding protein (39) . The present study demonstrates that binding of IM cannot be competed by IL3, GM-CSF, or IIr6. While IL3 and GM-CSF show potent stimulatory activity for the proliferation of human eosinophil precursors, IM primarily supports the terminal maturation of eosinophils (40, 41) . The kinetics of IL5R expression on HL60, as shown in Fig. 2 , coincides with the appearance of cells with a mature eosinophil phenotype (23) , supporting the hypothesis that IM acts at a later stage during eosinophilopoiesis .
Kinetic studies show that binding of radiolabeled hIL5 at 37°C is rapid and saturable. Scatchard analysis of equilibrium binding at 4°C provides evidence for a single class of binding sites with a Kd of 1-5 x 10' 11 M . The crosslinking 689 Plaetinck et al .
experiments provide some structural information on IL5 binding molecules on HIr60 . Table 2 ) . We do not know if this reflects a difference in numbers of receptors per cell or whether the frequency of HL60 that differentiate to MR-positive cells varies from one experiment to another. However, ifwe assume that induced clone 15 cells display on average 1,000 binding sites/cell with a Kd of 30 pM, ti 10%, or 100 receptor/cell, are occupied at a halfmaximal proliferative dose of IIr5 (3 x 10 -12 M) . Binding of radiolabeled human j1r5 can be competed for with cold hIL5 and mIL5 at similar concentrations (Table  1) , and the number and affinity of binding sites for hIL5 and mIL5 are comparable (Table 2 ) . Both mIL5 and hIL5 inhibit the formation of 35 S-mIL5-crosslinked complexes (Fig. 5 B) , which shows that they interact with the same membrane components . Consistent with these findings, we found that mIL5 has similar specific biological activity on HIr60 proliferation as hIL5 (Table 3) . This is apparently in contradiction with the results of Clutterbuck et al . (12) , who found that mIL5 is N20-fold less active on human bone marrow than on homologous bone marrow. Since IM has been shown to potentiate some eosinophil functions, such as antibody-dependent cytotoxicity (42) and the production of superoxide anion (7), it may well be that IL5, besides its growth-stimulating activity, has other effects on H1r60. Indeed, it has been reported that IM can upregulate mRNA levels for the granule contained proteins eosinophil cationic protein and eosinophil-derived neurotoxin, in an eosinophilic subline of HL60 (43) .
As mentioned before, on murine B cells, high and low affinity IM binding sites can be detected. Experimental data suggest that only the high affinity receptor can transmit a biological signal (15) . Crosslinking of radiolabeled IL5 (14, 15, 17) , and the characterization of cell surface molecules by anti-IL5R mAbs (16, 17) , revealed that at least two polypeptides (45-60 M L chain ; and 130-140 M H chain) comprise the IL5R. From their results, Mita et al. (15) concluded that the H chain is associated with the high affinity IL5R . Apparently, there is a good correlation between the amount of low affinity receptors on a particular cell line and the abundance of the L chain, as detected by affinity crosslinking. Based on these data, two models for the I1r5R have been proposed : (a) H and L chains correspond to high and low affinity binding sites, respectively; and (b) IL5 binds with low affinity to the L chain, and the high affinity receptor is composed of the H and L chain, a situation comparable with the I1r2R (44). On HIr60, we can detect IL5 binding sites with a Kd similar to that of the high affinity IIr5R on murine B cells. Affinity crosslinking indicates that membrane-bound IIr5 is associated with two polypeptides with molecular masses comparable with H and L IIr5R chains on murine B cells . Induction of 116 binding on HIr60 correlates with a, concomitant increase in intensity of the two crosslinked complexes (Fig.  5 A) . Furthermore, butyrate treatment increases the number of binding sites but does not alter significantly their affinity (Table 2) . Together, these observations suggest that both polypeptides form part of the high affinity receptor on human eosinophils, which would be compatible with the second model for the mouse receptor.
Assuming that the IIr5R on HIr60 is related-to that on mouse B cells, we think of two possible explanations why we only find high affinity receptors . Perhaps the L chain on HIr60, in contrast to its counterpart on mouse B cells, cannot bind 11,5 independently of the H chain . Alternatively, there is an excess ofH chain at the cell surface, so that all thebinding sites are converted to high affinity receptors. This hypothesis
